PINK1 and adrenal cortex carcinoma: This group was classified as poor-outcome with the targeted PCR marker BUB1B-PINK1; (ii) a group of more indolent ACC, enriched in localized, low-grade tumors, showing low rates of recurrence (4/28, 14%) and death (3/28, 11%).